Correlation Between Ravenquest Biomed and FSD Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ravenquest Biomed and FSD Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ravenquest Biomed and FSD Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ravenquest Biomed and FSD Pharma Class, you can compare the effects of market volatilities on Ravenquest Biomed and FSD Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ravenquest Biomed with a short position of FSD Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ravenquest Biomed and FSD Pharma.

Diversification Opportunities for Ravenquest Biomed and FSD Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ravenquest and FSD is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ravenquest Biomed and FSD Pharma Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSD Pharma Class and Ravenquest Biomed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ravenquest Biomed are associated (or correlated) with FSD Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSD Pharma Class has no effect on the direction of Ravenquest Biomed i.e., Ravenquest Biomed and FSD Pharma go up and down completely randomly.

Pair Corralation between Ravenquest Biomed and FSD Pharma

If you would invest  8.99  in FSD Pharma Class on September 17, 2024 and sell it today you would earn a total of  0.00  from holding FSD Pharma Class or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Ravenquest Biomed  vs.  FSD Pharma Class

 Performance 
       Timeline  
Ravenquest Biomed 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ravenquest Biomed has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ravenquest Biomed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
FSD Pharma Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FSD Pharma Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, FSD Pharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Ravenquest Biomed and FSD Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ravenquest Biomed and FSD Pharma

The main advantage of trading using opposite Ravenquest Biomed and FSD Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ravenquest Biomed position performs unexpectedly, FSD Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSD Pharma will offset losses from the drop in FSD Pharma's long position.
The idea behind Ravenquest Biomed and FSD Pharma Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals